Document Detail


Role of bradykinin in myocardial preconditioning.
MedLine Citation:
PMID:  8071859     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of bradykinin in the cardioprotective action of ischemic preconditioning was investigated in an anesthetized, open-chest rabbit model of acute coronary occlusion. A branch of the left main coronary artery was reversibly ligated to produce ischemia followed by reperfusion, after which the degree of myocardial necrosis (infarct size as a percent of area at risk) was assessed by tetrazolium staining. Before 30 min of coronary occlusion, rabbits received either ischemic preconditioning (5 min occlusion followed by 10 min reperfusion), no preconditioning, H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH (HOE 140) i.v. (bradykinin receptor antagonist, 1 micrograms/kg) plus preconditioning, HOE 140 alone, a 5-min intra-atrial bradykinin infusion (250 micrograms/kg/min) followed by a 10-min recovery period or HOE 140 plus bradykinin infusion with 10 min recovery. Systemic hemodynamic responses were similar between treatment groups except that both bradykinin infusion groups had a significantly depressed rate of left ventricular pressure development (LV+dP/dtmax) after the 10-min recovery period. Preconditioning reduced infarct size significantly (12 +/- 2%, compared to non-preconditioned controls at 41 +/- 6%), whereas pretreatment with HOE 140 abolished the cardioprotective effect (41 +/- 4%). In addition, bradykinin infusion reduced infarct size significantly (16 +/- 1%), an effect which was also prevented by HOE 140 (41 +/- 5%). HOE 140 alone did not exacerbate the degree of myocardial necrosis (43 +/- 4%). Myocardial area at risk as a percentage of total left ventricular mass was not different between the six treatment groups. The results indicate that endogenously generated bradykinin may mediate the cardioprotective events associated with ischemic preconditioning.
Authors:
T M Wall; R Sheehy; J C Hartman
Related Documents :
8443909 - Loss of myocardial protection after preconditioning correlates with the time course of ...
16507749 - Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.
10225309 - Does hypothermia or hyperkalemia influence the preconditioning response?
8419009 - Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity durin...
20592769 - Sphingosine protects aging hearts from ischemia/reperfusion injury: superiority to sphi...
15450109 - Adenosine a receptors are necessary for protection of the murine heart by remote, delay...
8916479 - Decreased baroreflex sensitivity in patients with stable coronary artery disease is cor...
402219 - Myocardial bridges in man: clinical correlations and angiographic accentuation with nit...
24103569 - Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  270     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1994 Aug 
Date Detail:
Created Date:  1994-09-28     Completed Date:  1994-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  681-9     Citation Subset:  IM    
Affiliation:
Cardiovascular Diseases Research Unit, Upjohn Laboratories, Upjohn Company, Kalamazoo, Michigan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
Bradykinin / analogs & derivatives,  pharmacology,  physiology*
Female
Heart / drug effects
Hemodynamics / drug effects
Male
Molecular Sequence Data
Myocardial Ischemia / physiopathology*
Myocardial Reperfusion Injury / physiopathology*,  prevention & control
Rabbits
Chemical
Reg. No./Substance:
130308-48-4/icatibant; 58-82-2/Bradykinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guin...
Next Document:  Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of n...